and added Peter Cheung as senior scientist in pharmaceutical discovery...Nymox Pharmaceutical Corp., of Maywood, N.J., appointed Paul Kraus clinical consultant

IDEC Pharmaceuticals Corp., of San Diego, appointed Michael Wiebe vice president, quality...and named Lorella Donato senior director of the ligand services group at its St. Laurent site

IDEC Pharmaceuticals Corp., of San Diego, promoted Edward Rodriguez to vice president, finance and controller

Aradigm Corp., of Hayward, Calif., appointed Stan Benson and Igor Gonda to its board...Incara Pharmaceuticals Corp., of Research Triangle Park, N.C., elected Eugene McDonald to its board

Nymox Pharmaceutical Corp., of Maywood, N.J., appointed Thomas Hudson and Joe Dylewski scientific consultants

Delsys Pharmaceutical Corp., of Monmouth Junction, N.J., appointed Paul Okarma senior director of regulatory affairs...and Motohiro Ueda president & representative director, Elan Pharma K.K., Japan

IDEC Pharmaceuticals Corp., of San Diego, appointed Paul Grint chief medical officer and senior vice president, clinical research and development

Delsys Pharmaceutical Corp., of Monmouth Junction, N.J., appointed Ronald Spair as vice president of finance and chief financial officer

Delsys Pharmaceutical Corp., of Monmouth Junction, N.J., appointed David Friend senior director of formulations...Luminex Corp., of Austin, Texas, appointed Gail Page executive vice president and chief operating officer

IDEC Pharmaceuticals Corp., of San Diego, promoted Phillip Schneider and Connie Matsui to senior vice presidents

Incara Pharmaceuticals Corp., of Research Triangle Park, N.C., named Robert Susick vice president, cell technologies, and Richard Gammans senior vice president, antioxidant therapies...and Scott Rakestraw executive director of therapeutics business development

Nymox Pharmaceutical Corp., of Maywood, N.J., named Allan Reimer vice president for technology acquisition and development...and Arnold Freedman, of the Dana-Farber Cancer Institute in Boston...and named James O'Connell vice president of business development

and Florence Wambugu, director of the International Service for the Acquisition of Agri-biotech Applications in Nairobi, Kenya...Idec Pharmaceuticals Corp., of San Diego, named Wolfgang Berthold senior vice president of biopharmaceutical sciences

The company also named Charles Bergeron, chief financial officer, interim president. • Genentech Inc., of South San Francisco, promoted Daniel Sulzbach to vice president, information resources. • Ilex Oncology Inc., of San Antonio, Texas, named Al Jecminek vice president of business development and intellectual property counsel. • InterMune Pharmaceuticals Inc., of Palo Alto, Calif., hired Nzeera Virani-Ketter as vice president of clinical research. • Memory Pharmaceuticals Corp., of New

and Robert Urban, to senior director, technical operations. • Cypress Bioscience Inc., of San Diego, promoted Judith Doe to vice president of marketing and sales. • Cypros Pharmaceutical Corp., of Carlsbad, Calif., named John Lee vice president, sales and marketing. • Delsys Pharmaceutical Corp., of Princeton, N.J., appointed Ashok Katdare senior director of formulation. • Desmos Inc., of San Diego, named to its scientific board Mina Bissell, director of the life sciences division of the

and Kazumi Shiosaki vice president, drug discovery. • Nabi, of Boco Raton, Fla., appointed Bruce Farley senior vice president, manufacturing operations. • Xenogenics Corp., of San Diego, a subsidiary of Exten Industries Inc., also of San Diego, named to its scientific board Alessandra Colantoni, research associate with the Department of Medicine in the Liver Transplant Service of the Division of Gastroenterology at Loyola University in Chicago. • CuraGen Corp., of New Haven, Conn., appointed

and development, and appointed Krisztina Zsebo, vice president, DUROS research and development. * Argonex Inc., of Charlottesville, Va., appointed J. Mark Braughler, president, and Ramila Philip, vice president, immunology and clinical affairs. * Bearsden Bio Inc., of Aston, Pa., named to its board of directors Sidney Hecht, a professor of chemistry at the University of Virginia, and Patrick Burns, senior consultant to Early Stage Enterprises. * Bio-Technology General Corp., of Iselin, N.J

Eos Biotechnology Inc., of South San Francisco, named Gayle Mills vice president, business development. * Geron Corp., of Menlo Park, Calif., named to its board of directors Gary Neil, president and CEO of Crescendo Pharmaceuticals Corp. * Genzyme Corp., of Cambridge, Mass., named Lisa Raines senior vice president of government relations. * Humascan Inc., of Cranford, N.J., appointed Chris Blaxland president and chief executive officer. * ID Biomedical Corp., of Vancouver, British

and Daniel Von Hoff, director of the Institute for Drug Development at the Cancer Therapy Research Center in San Antonio. * Alza Corp., of Palo Alto, Calif., named Susan Rinne vice president of regulatory affairs. * Angeion Corp., of Minneapolis, appointed to its board of directors Stephen Wilson, executive vice president and chief financial officer of Computer Motion Inc. * Ariad Pharmaceuticals Inc., of Cambridge, Mass., named to its board of directors Ralph Snyderman, of the Duke